MedTrace Logo

The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy

NCT05061459 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2021-09-29

No results posted yet for this study

Summary

1. To evaluate expression levels of circANKRD36 in the development and progression of DN.
2. To investigate correlation between expression levels of circANKRD36 and stages of DN.
3. To investigate correlation between expression levels of circANKRD36 and pro-inflammatory cytokine (TNF-α and IL-6) in T2DM patients with CKD.

Conditions

  • Diabetic Nephropathy

Interventions

GENETIC

circANKRD36 as a new biomarker

expression levels of circANKRD36 in the development and progression of DN

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-31
Primary Completion
2023-10-31
Completion
2023-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05061459 on ClinicalTrials.gov